Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
12.95
-0.84 (-6.11%)
Feb 24, 2025, 3:13 PM EST - Market open
Aardvark Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Feb '25 Feb 24, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 277 | - | - |
| Enterprise Value | 212 | - | - |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.02 |
| Quick Ratio | 31.53 | 7.23 | 27.07 |
| Current Ratio | 31.65 | 7.50 | 27.72 |
| Return on Equity (ROE) | - | -57.47% | - |
| Return on Assets (ROA) | - | -33.96% | - |
| Return on Capital (ROIC) | - | -36.34% | - |
| Buyback Yield / Dilution | -2.06% | -1.78% | - |
| Total Shareholder Return | -2.06% | -1.78% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.